Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers

PurposeOur recent study showed a high rate of HBsAg clearance in inactive HBsAg carriers (IHCs) treated with pegylated IFN (PEG-IFN). To better understand the immune-mediated component of HBsAg clearance, this study investigated the role of serum immunoglobulin G (IgG) and its subclasses in predicti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hong Li, Xiao Lin, Lili Liu, Ling Qin, Yanhong Zheng, Xiaohui Liu, Xinhuan Wei, Shan Liang, Yali Liu, Jing Zhang, Xinyue Chen, Zhenhuan Cao
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2022-04-01
Col·lecció:	Frontiers in Immunology
Matèries:	inactive HBsAg carriers HBsAg clearance pegylated interferon lgG predictor
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.864354/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!